Determinants of intertransfusion interval in children with transfusion-dependent thalassemia: a retrospective single-center cohort study in China
View abstract on PubMed
Summary
This summary is machine-generated.Genotype severity and red blood cell product type significantly impact transfusion intervals in pediatric transfusion-dependent thalassemia (TDT). Personalized transfusion strategies can optimize treatment and reduce complications for these young patients.
Area Of Science
- Pediatric Hematology
- Transfusion Medicine
- Thalassemia Research
Background
- Optimizing blood transfusion regimens is critical for managing children with transfusion-dependent thalassemia (TDT).
- Identifying factors influencing transfusion intervals is essential for improving patient care and treatment efficacy.
Purpose Of The Study
- To determine the key factors affecting intertransfusion intervals in pediatric patients with TDT.
- To analyze the impact of patient demographics, genotype, and red blood cell (RBC) product characteristics on transfusion frequency.
Main Methods
- A retrospective observational study of 21 pediatric β-thalassemia patients and 392 transfusions.
- Analysis included univariate tests, correlation analysis, and binary logistic regression to identify determinants of intertransfusion intervals.
- Multivariable linear regression evaluated factors influencing pre-transfusion hemoglobin levels.
Main Results
- Genotype severity (major vs. minor) and RBC product type (leukocyte-reduced RBC vs. washed RBC) independently influenced intertransfusion intervals.
- Age and weight negatively correlated with intertransfusion intervals.
- Patients with major genotypes had significantly lower pre-transfusion hemoglobin levels; leukocyte-reduced RBCs showed a hemoglobin advantage over washed RBCs.
Conclusions
- Genotype severity and RBC product type are significant determinants of intertransfusion intervals in pediatric TDT.
- Personalized transfusion strategies considering these factors are recommended for optimizing efficacy and minimizing complications.
- Adverse reactions, including febrile reactions and alloimmunization, were observed in 23.8% of patients.
Related Concept Videos
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

